BP003076: Biotinylated Human HLA-A*02:01&B2M&PRAME (ALYVDSLFFL) Monomer Protein with the C-His-Avi Tag
Source: The recombinant Biotinylated Human HLA-A*02:01&B2M&PRAME (ALYVDSLFFL) Monomer Protein, (amino acids Gly25-Thr305(HLA-A*02:01), Ile21-Met119(B2M) and ALYVDSLFFL peptide) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Biotinylated Human HLA-A*02:01&B2M&PRAME (ALYVDSLFFL) Monomer protein with the C-His-Avi tag at 1 ug/ml (100 ul/well) on the streptavidin precoated plate (5 ug/ml). Dose response curve for the recombinant Anti-HLA-A*02:01&B2M&PRAME (ALYVDSLFFL) Antibody protein with the C-hFc tag with the EC50 of 6.2 ng/ml determined by ELISA.
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.BP005766: Human VEGF R2/KDR Protein with the C-mFc Tag
Source: The recombinant Human VEGF R2/KDR Protein, (amino acids Ala20-Glu764) fused with a mFc tag at the C-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Human VEGF165 protein with the C-mFc tag 1 ug/ml (100 ul/Well) on the plate. Dose response curve for the recombinant Human VEGF R2 protein with the C-mFc tag with the EC50 of 42.3 ng/ml determined by ELISA.
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.
BP005397: Human VEGF R2/KDR Protein with the C-His-Avi Tag
Source: The recombinant Human VEGF R2/KDR Protein, (amino acids Ala20-Glu764) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Human VEGF R2 protein with the C-His-Avi tag at 0.5 ug/ml (100 ul/Well). Dose response curve for the recombinant Anti-VEGFR2 Antibody protein with the C-hFc tag with the EC50 of 5.5 ng/ml determined by ELISA.
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.